AP
Amylyx Pharmaceuticals, Inc.
Organization
Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts. The company focuses on discovering and developing novel therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative and metabolic disorders.
2 episodes featuring Amylyx Pharmaceuticals, Inc.
Stock Movers
Amylyx surges on trial success while Klarna plunges on weak guidance
This episode details how clinical breakthroughs and executive shakeups are driving stark divergence between winning biotech firms and struggling fintech giants.
Aug 18, 2026 · 7 min
Stock Movers
Amer Sports and Amylyx surge as Klarna plunges on missed expectations
Understanding these sharp corporate shifts highlights how clinical milestones and guidance adjustments rapidly redefine market winners and losers.
Aug 18, 2026 · 5 min